MUMBAI, India, Aug. 29 -- Intellectual Property India has published a patent application (202517072372 A) filed by Yale University; and Biohaven Therapeutics Ltd., New Haven, U.S.A., on July 30, for 'compounds and methods for treating, ameliorating, or preventing arthritis.'
Inventor(s) include Spiegel, David; Deramon, Edward; Mcdonald, David; and Marcin, Lawrence R.
The application for the patent was published on Aug. 29, under issue no. 35/2025.
According to the abstract released by the Intellectual Property India: "The disclosure describes compounds, which in non-limiting aspects contain an asialoglycoprotein receptor (ASGPR) binding moiety and an anti-CCP (anti-cyclic citrullinated peptide binding moiety). The compounds are useful in preventing, treating, and/or ameliorating various types of arthritis, including rheumatoid arthritis (RA), in a subject when administered in therapeutically effective amounts."
The patent application was internationally filed on Jan. 31, 2024, under International application No.PCT/US2024/013767.
Disclaimer: Curated by HT Syndication.
